Pomerantz To Lead Securities Suit Against WuXi
Law firm Pomerantz will serve as lead counsel in a proposed class action accusing pharmaceutical research and development company WuXi of keeping investors in the dark about plans to spin off...To view the full article, register now.
Already a subscriber? Click here to view full article